Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0AA8R
|
|||
Former ID |
DIB005129
|
|||
Drug Name |
Sotirimod
|
|||
Synonyms |
R-850; S-30594; Sotirimod (actinic keratosis); Sotirimod (actinic keratosis), 3M/Meda
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Keratosis [ICD-11: ED56; ICD-10: L57.0] | Phase 2 | [1] | |
Company |
3M Pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C14H17N5
|
|||
Canonical SMILES |
CC1=NC2=C(N1CC(C)C)C3=C(C=CC=N3)N=C2N
|
|||
InChI |
1S/C14H17N5/c1-8(2)7-19-9(3)17-12-13(19)11-10(18-14(12)15)5-4-6-16-11/h4-6,8H,7H2,1-3H3,(H2,15,18)
|
|||
InChIKey |
ZXBCLVSLRUWISJ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 227318-75-4
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med. 2007 May;13(5):552-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.